GSK Logo

site-logo

Are you a Healthcare Professional? Visit the Healthcare Professional website.

Volibris

ambrisentan

Product Overview

This page is currently being updated and will be available shortly.

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
Volibris is a trademark of Gilead Colorado, Inc. which GSK is using under exclusive license.

M.C : Last updated March 2014 : UK/COM/0020/14

Links & Resources

GSK does not recommend, endorse or accept liability for sites controlled by third-parties.